Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
The Colt Group Acquires Plant Services, Inc.
-
The Eclipse Foundation Unveils 2024 IoT & Embedded Developer Survey Results
-
U.S. Energy Corp. to Present at the Emerging Growth Conference on December 4, 2024
-
Rehmann Foundation Grants $100,000 to Support Local Organizations
-
Troilus Announces Key Leadership Appointment and Provides Operational Update
-
Lantronix Announces Participation in 13th Annual NYC Summit
-
Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires
-
KVH Introduces TracNet™ Coastal and TracNet Coastal Pro 5G/Wi-Fi Terminals and Cellular Data Plans
-
Nusano Names Medical Radioisotopes Advisory Board
-
FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer
-
Coherus Announces Agreement to Divest UDENYCA® Franchise for up to $558 million to Intas Pharmaceuticals Ltd.
-
Keros Therapeutics Announces Global License Agreement with Takeda to Advance Elritercept
-
G-III Apparel Group Announces Date for Third Quarter 2025 Results
-
Ero Copper Announces Updated Mineral Reserve and Resource Estimates for the Xavantina Operations
-
Kinevant Sciences Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis
-
Terns Pharmaceuticals Announces Positive Early Data from Phase 1 CARDINAL Trial of TERN-701 for Chronic Myeloid Leukemia
-
Roivant Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis
-
Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment
-
Predictive Oncology Announces Progress in Ongoing Evaluation of Strategic Alternatives
-
Vivid Seats to Participate in Raymond James 2024 TMT & Consumer Conference
-
PyroGenesis Plasma-Based Solution Achieves Successful Destruction of PFAS “Forever Chemicals”
-
Diagonal Therapeutics to Present Data at ASH 2024 Demonstrating the Economic and Clinical Burden of Hereditary Hemorrhagic Telangiectasia (HHT)
-
Chemomab to Participate in Oppenheimer’s Movers in Rare Disease Summit
-
Spur Therapeutics Announces Development Candidate in Parkinson’s Disease Gene Therapy Program
-
Meaningful Work and Flexibility Distinguish the Fortune Best Workplaces for Parents
-
Vivid Seats to Participate in Raymond James 2024 TMT & Consumer Conference
-
YieldMax™ Launches the Target 12™ Semiconductor Option Income ETF (SOXY)
-
Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer
-
Burning Rock Announces 2024 Annual General Meeting to be Held on December 31, 2024
-
CLICK announced to expand service to the Community Care Service Voucher scheme for elderly (CCSV scheme) in Hong Kong
-
FISHER HOUSE FOUNDATION RECEIVES “FOUR STARS” FOR 21st YEAR FROM CHARITY NAVIGATOR, A+ FROM CHARITY WATCH
-
Renovi Launches $RNVI Token, Transforming In-Game Advertising with Blockchain
-
COUR Pharmaceuticals Enters Collaboration and Licensing Agreement with Genentech to Develop and Commercialize Tolerogenic Therapy for the Treatment of an Autoimmune Disease
-
Information on share capital and voting rights - November 2024
-
Financial calendar 2025 for the companies of the Nykredit Group
-
The Cooperative Logistics Network Celebrates 10 Years in the Freight Forwarding Industry with more than 360 members
-
Hooker Furnishings Declares Quarterly Dividend
-
Dynamite Blockchain to Acquire Kaspa Mining Limited
-
The Honest Talk Announces Partnership with Air Canada as Platinum Partner
-
Titan Mining Announces Maiden Mineral Resource Estimate for 100% Owned Kilbourne Graphite Project at the Empire State Mine
-
Defiance Launches NVOX, the First 2X Leveraged Single-Stock ETF on Novo Nordisk
-
Cartesian Therapeutics Announces Positive Updated Results from Phase 2b Trial of Descartes-08 in Participants with Myasthenia Gravis and Outlines Design of Planned Phase 3 Trial
-
Marriott Recognizes Crestline Hotels & Resorts with Its Prestigious Serve 360 Award
-
Texas Mineral Resources Acquires Historic Carlisle Mine in New Mexico
-
Rhythm Pharmaceuticals Announces ▼ IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Bardet B
-
Priothera to Present Trial in Progress Poster for Mocravimod at 2024 American Society of Hematology (ASH) Annual Meeting
-
Vow ASA: Notification of trade – primary insider/close associate
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Volex plc
-
Statement re Standard form for notification of major holdings
-
Sky Quarry Announces Publication of Zacks Small-Cap Research Report:
